ShareHope Medicine Co Ltd (8403) — Capital Reinvestment Ratio
ShareHope Medicine Co Ltd (8403) has a Capital Reinvestment Ratio of 0.35x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$113.37 Million) in capital expenditures (NT$39.14 Million). See ShareHope Medicine Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ShareHope Medicine Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks ShareHope Medicine Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 8403 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ShareHope Medicine Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for ShareHope Medicine Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see market cap of ShareHope Medicine Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | NT$364.12 Million | NT$131.81 Million | ▲ +3.8% |
| 2024 | 0.35x | NT$266.68 Million | NT$93.02 Million | ▼ -67.6% |
| 2023 | 1.08x | NT$257.13 Million | NT$277.20 Million | ▼ -46.1% |
| 2022 | 2.00x | NT$642.47 Million | NT$1.28 Billion | ▲ +372.7% |
| 2021 | 0.42x | NT$360.10 Million | NT$152.26 Million | ▼ -16.6% |
| 2020 | 0.51x | NT$717.74 Million | NT$364.00 Million | ▲ +144.7% |
| 2019 | 0.21x | NT$502.62 Million | NT$104.17 Million | ▼ -93.1% |
| 2018 | 3.02x | NT$33.91 Million | NT$102.27 Million | ▲ +6.4% |
| 2017 | 2.83x | NT$62.76 Million | NT$177.91 Million | — |